These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15453323)

  • 1. [Clinical view of acute hepatitis B].
    Tanaka N; Arakawa Y; Moriyama M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():242-7. PubMed ID: 15453323
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prediction of fulminant hepatitis in severe acute hepatitis B].
    Michitaka K; Onji M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():269-73. PubMed ID: 15453328
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnostic tests: Serological markers of hepatitis B virus].
    Daikoku M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():404-7. PubMed ID: 16111286
    [No Abstract]   [Full Text] [Related]  

  • 4. [The importance of clinical laboratory data in the differential diagnosis of group hepatitis B diseases].
    Orgel' MIa; Tychinskiĭ NV; Rogotskaia LT; Reznikov AP; Muliar IS; Sapego ZhK
    Vrach Delo; 1991 Mar; (3):40-3. PubMed ID: 1645896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis B].
    Kashiwagi S
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():236-40. PubMed ID: 12722220
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of hepatitis B markers in previously diagnosed hepatitis patients during a one-year period].
    Poyraz O; Gökoğlu M; Oztop Y
    Mikrobiyol Bul; 1993 Oct; 27(4):314-20. PubMed ID: 8264444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IgM anti-HBc in the differential diagnosis of co- and HDV superinfection].
    Fedorchenko SV; Vozianova SV
    Ter Arkh; 1991; 63(11):55-8. PubMed ID: 1810065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance and treatment protocols to detect and treat hepatitis B virus reactivation in hepatitis B surface antigen-negative/antibody to hepatitis B core antigen-positive patients receiving chemotherapy for onco-hematologic malignancies.
    Marignani M; Marzano A
    J Clin Oncol; 2011 Mar; 29(8):e210; author reply e211. PubMed ID: 21220585
    [No Abstract]   [Full Text] [Related]  

  • 9. [Detection of hepatitis B core antibody (including IgM and IgA class antibodies)].
    Tsuge M; Chayama K
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():129-33. PubMed ID: 15453301
    [No Abstract]   [Full Text] [Related]  

  • 10. [Markers of hepatitis B virus in chronic liver diseases].
    Maleev A; Ognianov M; Ninova D
    Ter Arkh; 1987; 59(7):13-7. PubMed ID: 3672351
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hepatitis B virus genotypes and mutations in asymptomatic carriers].
    Orito E; Mizokami M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():233-7. PubMed ID: 15453321
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic HBsAg-negative liver disease. Presence of the markers of hepatitis B virus (HBV) infection and their possible meaning].
    Diodati G; Pontisso P; Pornaro E; Stenico D; Bonetti P; Realdi G; Ruol A
    Ann Ital Med Int; 1987; 2(3):195-200. PubMed ID: 3275282
    [No Abstract]   [Full Text] [Related]  

  • 13. [HBe antigen and HBe antibody].
    Arase Y
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():124-8. PubMed ID: 15453300
    [No Abstract]   [Full Text] [Related]  

  • 14. [Delta hepatitis as a mixed infection].
    Fedorchenko SV; Vovk AD; Vozianova SV
    Vrach Delo; 1990 Mar; (3):5-8. PubMed ID: 2195767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis B virus markers in the internist's practice].
    Ivashkin VT; Khazanov AI; Ivlev AS; Vasil'eva AP; Rumiantsev ON; Krivoruchko VA; Lytsar' BN; Izgorodin AS
    Klin Med (Mosk); 1991 Sep; 69(9):51-4. PubMed ID: 1803151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
    Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
    J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
    [No Abstract]   [Full Text] [Related]  

  • 17. [IgM and IgA antibodies to hepatitis B core antigen].
    Suga M
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):258-64. PubMed ID: 12442395
    [No Abstract]   [Full Text] [Related]  

  • 18. Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment.
    Gérolami R; Henry M; Borentain P; Colson P; Botta D; Tamalet C
    Clin Infect Dis; 2005 Feb; 40(4):e24-7. PubMed ID: 15712066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence.
    Núñez M
    Hepatology; 2010 Mar; 51(3):1087-8. PubMed ID: 19960553
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg.
    Antar W; El-Shokry MH; Abd El Hamid WA; Helmy MF
    Transfus Med; 2010 Dec; 20(6):409-13. PubMed ID: 20573069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.